About Allena Pharmaceuticals, Inc
Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The company’s lead product candidate is reloxaliase, an oral enzyme therapeutic that is in phase 3 clinical program for the treatment of hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It also develops ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and moderate to severe chronic kidney diseases. Allena Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Newton, Massachusetts. Address: One Newton Executive Park, Newton, MA, United States, 02462
Allena Pharmaceuticals, Inc News and around…
Latest news about Allena Pharmaceuticals, Inc (ALNA) common stock and company :
Gainers Ascendis Pharma (NASDAQ:ASND) stock moved upwards by 20.07% to $148.1 during Wednesday's after-market session. This security ...
Gainers CohBar (NASDAQ:CWBR) stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The ...
Gainers CohBar, Inc. (NASDAQ: CWBR) shares rose 78.3% to $2.30 in pre-market trading after the company reported results from the ...
Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 45.98% to $2.22 during Wednesday's regular ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Penny stocks are a study in contrasts. They’re equities whose share price stands below $5, and that low price opens up a wide field of possibilities. Chief among these are the ultra-low cost of entry, combined with triple-digit upside potentials. These are stocks that truly can jump sky-high when conditions are right. But penny investors had better be risk tolerant, because these stocks also offer a range of possible downsides. First, there’s that ultra-low cost of entry; it raises the question,
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance ...
Gainers Datasea Inc. (NASDAQ: DTSS) climbed 85% to $5.42. Datasea’s subsidiary Shuhai Zhangxun Information Technology Co., ...
Wednesday morning saw 57 companies set new 52-week lows. Noteworthy Points: Campbell Soup (NYSE:CPB) was ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! We're kicking off the day with a look at winners and losers of the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now.
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) shares rose 35.6% to $3.54 in pre-market trading after jumping around 12% on ...
Allena Pharmaceuticals Inc(NASDAQ: ALNA) has announced aregistered direct offering of 21.3 million sharesand ...
Gainers scPharmaceuticals (NASDAQ:SCPH) shares increased by 9.27% to $7.19 during Tuesday's after-market session. At the close, ...
Allena Pharmaceuticals Inc(NASDAQ: ALNA)provided progress updateson its ALLN-346 and reloxaliase (ALLN-177) ...
Webinar Scheduled for Wednesday, June 16th @ 12 pm EDT
Gainers MultiPlan (NYSE:MPLN) stock increased by 17.31% to $7.21 during Thursday's regular session. Trading volume ...
Allena Pharmaceuticals (ALNA) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Allena Pharmaceuticals, Inc (ALNA) is a NASDAQ Common Stock listed in Biotechnology, Common Stock, Healthcare
